BPC-157 research guide
A factual reference for laboratories working with BPC-157: what the material is, how it is handled and stored, how to read its certificate of analysis, and how to order it in Canada. It is written for in-vitro research and makes no claims about effects in people or animals.
What is BPC-157?
BPC-157 is a synthetic peptide of 15 amino acids. Its sequence, Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val, corresponds to a fragment of a larger protein first described in human gastric juice. The name is an abbreviation of "body protection compound" and the number refers to the fragment designation used in the original publications.
Structurally the peptide is notable for a run of three prolines at positions 3 to 5 and a fourth proline at position 8. Proline restricts rotation of the peptide backbone, so the chain is less flexible than its length would suggest. It contains no cysteine and therefore has no disulfide bonds, and it carries a net negative charge at neutral pH because of its two aspartate and one glutamate residues.
Synergy Research supplies BPC-157 as a lyophilised solid made by solid-phase peptide synthesis. The same compound is also offered in a capsule format and in a 10-vial kit, each with its own product page.
Specification summary
Values are taken from the product page and the public PubChem record. Each lot is confirmed against them by the independent testing reported on the certificate of analysis.
Research context
BPC-157 appears frequently in the cell-culture literature. Published work has examined fibroblast migration in scratch-wound assays, expression of growth-factor receptors and markers of angiogenic signalling in endothelial cells, and nitric-oxide pathway markers. It has also been used as a reference compound in studies of peptide stability in simulated gastric fluid, where its proline-rich backbone is relevant.
Despite the volume of preclinical publications, BPC-157 is not an approved drug in any jurisdiction, and it is listed by several sports anti-doping bodies as a prohibited substance. The compound is supplied here so that laboratories can carry out their own in-vitro work; this page does not report or interpret outcomes.
Synergy Research does not evaluate, summarise or endorse the findings of any study. The material is supplied so that laboratories can design and run their own in-vitro experiments.
Storage and handling for laboratory use
Unopened vials of BPC-157 should be stored sealed, in a cool, dry place away from light. Refrigeration at 2 to 8 °C is used for longer storage, and freezing at -20 °C is common practice for lyophilised material held for many months. The lyophilised solid is far more stable than any solution, so vials should remain unopened until they are needed.
BPC-157 has been reported as comparatively stable in aqueous solution, which is attributed in part to its proline content. That stability still depends on sterile handling and refrigeration of any solution.
Allow a cold vial to reach room temperature before removing the cap or piercing the stopper, so that moisture from the air does not condense on the solid. Record the lot number from the label in your laboratory notebook; it is the link between the vial and its certificate.
Reconstitution in the laboratory
Lyophilised material is dissolved immediately before use in a sterile diluent appropriate to the assay. Bacteriostatic water (0.9% benzyl alcohol), sterile water for laboratory use, or a neutral buffer such as phosphate-buffered saline are common choices. The diluent is added slowly down the inside wall of the vial rather than directly onto the powder, and the vial is swirled or rolled gently until the solid dissolves.
The peptide dissolves readily in sterile or bacteriostatic water and in neutral buffers. It is acidic, so dissolving it in an acidic diluent is not necessary and may be counterproductive.
The volume of diluent determines the concentration of the resulting solution; laboratories calculate it from the stated vial content and the molar mass given above. Solutions should be labelled with compound, concentration, lot number and date, kept refrigerated and protected from light, and discarded according to your own stability data. Repeated freeze-thaw cycles should be avoided; if a solution must be stored frozen, divide it into single-use aliquots first.
How to read the Certificate of Analysis
Every lot Synergy Research sells is tested by an independent Canadian laboratory, and the resulting certificate is published on the Certificates of Analysis page. A certificate has three parts worth checking before you use a vial.
- Identity. Mass spectrometry measures the molecular mass of the material and compares it with the theoretical value. For BPC-157 the mass spectrometry result should show an observed mass close to 1419.5 g/mol, often seen as the [M+H]+ ion near 1420 or the [M+2H]2+ ion near 710.
- Purity. Reversed-phase HPLC with UV detection separates the main compound from related impurities. The area of the main peak as a percentage of total peak area is reported as purity. Look for the chromatogram itself, not only the number.
- Traceability. The lot number on the certificate should match the number printed on your vial, and the certificate should name the testing laboratory and the date of analysis.
If a certificate for your lot is not yet posted, email [email protected] with the lot number and it will be sent when the laboratory report is in.
Frequently asked questions
What is the amino acid sequence of BPC-157?
The sequence is GEPPPGKPADDAGLV, a 15-residue chain with a molar mass of 1419.5 g/mol. It contains four prolines and no cysteine.
Is BPC-157 approved as a medicine anywhere?
No. BPC-157 has not been approved by any drug regulator, and it is on the prohibited list of several anti-doping organisations. It is supplied only for in-vitro research.
What sizes does Synergy Research offer?
BPC-157 is available as 5mg and 10mg lyophilised vials, as a 10-vial kit, in a two-peptide mixture with TB-500, and in capsule format.
How is purity determined on the COA?
An independent laboratory runs reversed-phase HPLC with UV detection. The area of the main peak as a percentage of all peaks is reported as purity, and mass spectrometry confirms the molecular identity.
How should BPC-157 solutions be handled?
Reconstitute with sterile or bacteriostatic water, keep refrigerated and protected from light, and avoid repeated freeze-thaw cycles. Handle the solution as a laboratory reagent, not a consumable.
Buy BPC-157 in Canada
Synergy Research supplies BPC-157 as 5mg and 10mg vials. Orders ship across Canada by Canada Post Xpresspost with tracking, and payment is accepted by Interac e-Transfer or card. Every vial is matched to a published certificate of analysis.
View BPC-157 product page →See also: how to choose a research peptide supplier in Canada and the certificate archive.
For Research Use Only. Not for human or animal consumption, and not for use in diagnostic or therapeutic procedures. Nothing on this page describes, recommends or implies any use of this material in people or animals. See our Research Use Policy.